Variants of the HCP5 gene are associated with an increased risk of developing Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), which are severe and potentially life-threatening cutaneous drug reactions [58,59]. The gene discussed is HCP5; the disease is toxic epidermal necrolysis.